Assessment of Salivary and Lacrimal Gland Dysfunction after Radioiodine Therapy Using 99mTc-Pertechnetate Scintigraphy

نویسندگان

  • AHMED A. KANDEEL
  • MAHASSEN A. ABOU-GABAL
  • TAMER A. GHEITA
  • Ahmed A. Kandeel
چکیده

Background: Iodine-131 (I-131) is an effective treatment for differentiated thyroid carcinomas (DTC) after surgery. Salivary and lacrimal gland dysfunction has been described in patients receiving high doses of 1-131 due to radiation damage to salivary and lacrimal glands. Objective: This prospective study was conducted to determine the short term effect of oral 1-131 therapy administered to thyroid cancer patients on the function of salivary gland by 99mTcpertechnetate scintigraphy with semiquantitative analysis and assessment of lacrimal gland affection. Methods: Twenty patients with post-surgical DTC (mean age, 45.6±9.7 y) were referred for 1-131 therapy (mean dose 196±108 mCi). All patients had no symptoms or signs or drug history of Sicca syndrome. Before and 8-12 months after 1131 therapy, salivary gland function was estimated by sequential salivary gland scintigraphy after an intravenous injection of 185 MBq (5 mCi) 99mTc-pertechnetate with lemon stimulation at 15th min post-injection. Regions of interest (ROIs) were drawn over the four parotid and submandibular glands. Time-activity curves were generated and semiquantitative functional parameters were calculated for each gland to obtain the time at maximum count (Tmax). Clearance fraction (CF) was also calculated. Mean values of the bilateral glands were used for data analysis. Lacrimal gland function was carried out by Schirmer's test done before and after 1-131 therapy; wetting of 5mm or less was considered abnormal. Results: Tmax and CF of parotid and submandibular glands were normal in all patients with no clinical symptoms of xerostomia at base line study. On follow-up, 7 patients reported variable severity of xerostomia. However, 12 patients showed deterioration of their salivary indices with significant difference in the Tmax and CF values between 2 studies (p 0.03, 0.01 for parotid and 0.02, 0.02 for submandibular, respectively). There was a significant positive correlation between the given 1-131 dose and Tmax values (r 0.66p 0.002 for parotid and r 0.71p 0.001 for submandibular). There was a significant negative correlation between the given 1-131 dose and CF values (r-0.48 p 0.03 for parotid and r-0.49 p 0.03 for submandibular). Abnormal Schirmer's test was documented in 5 patients; yet, non-significant (p=0.41). Correspondence to: Dr. Ahmed A. Kandeel, The Department of Nuclear Medicine (NEMROCK), Faculty of Medicine, Cairo University Conclusion: The semiquantitative analysis method including the Tmax and clearance fraction parameters would enable objective assessment of salivary gland function and provide a reproducible means for moderate term follow-up after radioiodine therapy especially those who received total doses more than 150mCi and should be closely monitored for their salivary and lacrimal function after radioiodine therapy.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Salivary Gland Scintigraphy in Patients with Sjogren’s Syndrome: A local Experience with Dual-tracer

Objective(s): To review the findings of the patients with Sjögren’s syndrome (SS) having technetium-99m-pertechnetate (99mTc-pertechnetate) and gallium-67 citrate (Ga-67) salivary gland scintigraphy in the past eight years.Methods: The patients with SS, who were referred to our department for salivary gland scintigraphy during January 2008-December 2015 were studied using both 99mTc-pertechneta...

متن کامل

Radioiodine therapy effects on salivary gland function in patients with differentiated thyroid cancer [Persian]

Salivary gland involvement is one of the radioiodine therapy complications. Salivary gland scintigraphy in quantitative mode can accurately evaluate salivary gland function. Methods: Salivary gland scintigraphy was performed with Tc-99m Pertechnetate, at the time of iodine therapy as a basic study and then 3 weeks and 3 months afterwards. Ejection Fraction (EF) of parotid and submandibula...

متن کامل

Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.

UNLABELLED Salivary gland dysfunction has been described in patients undergoing radioiodine therapy but associated lacrimal gland dysfunction (sicca syndrome) has never been reported. We conducted a prospective cohort study with follow-up for up to 3 y in a tertiary care university center to determine the prevalence of sicca syndrome in patients after high-dose radioiodine treatment. METHODS ...

متن کامل

Salivary Gland Scintigraphy in Patients with Sjogren’s Syndrome: A local Experience with Dual-tracer

OBJECTIVES To review the findings of the patients with Sjögren's syndrome (SS) having technetium99-m-pertechnetate (99mTc-pertechnetate) and gallium67- citrate (Ga-67) salivary gland scintigraphy in the past eight years. METHODS The patients with SS, who were referred to our department for salivary gland scintigraphy during January -2008December 2015 were studied using both 99mTc-pertechnetat...

متن کامل

Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease

Introduction: High-dose radioactive iodine therapy in differentiated thyroid cancer (DTC) may adversely affect the salivary gland function. This study is aimed to evaluate the effect of radioactive iodine (RAI) with dose of 100 mCi in DTC patients compared to lower doses of less than 30 mCi in hyperthyroid cases. Methods: Fifty four patients (13 men and 41 women) age: 42.3±14.3 (21-71) years w...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014